Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ON vs MRNA✓SelectedUSD · MRNAON vs MRNA performance historyLatest closeAs of-7.43%11/20
Stock and ETF performance explorer

ON vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+250.3%
MRNA return
+786.4%
Excess return
-536.1%
Maximum drawdown
-70.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-7.4%-2.2%-5.3%-7.3%
7D-14.4%-12.7%-1.7%-13.6%
30D-20.9%-20.7%-0.3%-19.8%
3M-18.6%+46.3%-64.8%-20.9%
6M-44.8%+305.2%-350.0%-54.4%
YTD+12.4%+561.2%-548.9%-14.1%
1Y+35.5%+772.1%-736.6%-0.4%
3Y-13.9%+147.0%-160.9%-28.4%
5Y-3.9%-26.1%+22.1%-15.8%
All+250.3%+786.4%-536.1%+223.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling